These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 38397868)

  • 21. Catheter Ablation of VT in Non-Ischaemic Cardiomyopathies: Endocardial, Epicardial and Intramural Approaches.
    Bhaskaran A; Tung R; Stevenson WG; Kumar S
    Heart Lung Circ; 2019 Jan; 28(1):84-101. PubMed ID: 30385114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catheter ablation of ventricular tachycardia in patients with post-infarction cardiomyopathy.
    Nazer B; Gerstenfeld EP
    Korean Circ J; 2014 Jul; 44(4):210-7. PubMed ID: 25089131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term results of catheter ablation of idiopathic and structural ventricular tachycardia].
    Lucas P; Sciacca V; Sommer P; Fink T
    Herzschrittmacherther Elektrophysiol; 2023 Dec; 34(4):298-304. PubMed ID: 37855890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
    Arenal Á; Ávila P; Jiménez-Candil J; Tercedor L; Calvo D; Arribas F; Fernández-Portales J; Merino JL; Hernández-Madrid A; Fernández-Avilés FJ; Berruezo A
    J Am Coll Cardiol; 2022 Apr; 79(15):1441-1453. PubMed ID: 35422240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease.
    Kim YH; Sosa-Suarez G; Trouton TG; O'Nunain SS; Osswald S; McGovern BA; Ruskin JN; Garan H
    Circulation; 1994 Mar; 89(3):1094-102. PubMed ID: 8124795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-density substrate-guided ventricular tachycardia ablation: role of activation mapping in an attempt to improve procedural effectiveness.
    Carbucicchio C; Ahmad Raja N; Di Biase L; Volpe V; Dello Russo A; Trivedi C; Bartoletti S; Zucchetti M; Casella M; Russo E; Santangeli P; Moltrasio M; Tundo F; Fassini G; Natale A; Tondo C
    Heart Rhythm; 2013 Dec; 10(12):1850-8. PubMed ID: 24055940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation.
    Koplan BA; Soejima K; Baughman K; Epstein LM; Stevenson WG
    Heart Rhythm; 2006 Aug; 3(8):924-9. PubMed ID: 16876741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catheter Ablation of Scar-mediated Ventricular Tachycardia: Are Substrate-based Approaches Replacing Mapping?
    Hongo RH
    J Innov Card Rhythm Manag; 2019 Jun; 10(6):3707-3715. PubMed ID: 32477737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular Tachycardia Ablation - The Right Approach for the Right Patient.
    Sadek MM; Schaller RD; Supple GE; Frankel DS; Riley MP; Hutchinson MD; Garcia FC; Lin D; Dixit S; Zado ES; Callans DJ; Marchlinski FE
    Arrhythm Electrophysiol Rev; 2014 Nov; 3(3):161-7. PubMed ID: 26835085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the Ventricular Tachycardia Circuit Between Patients With Ischemic and Nonischemic Cardiomyopathies: Detailed Characterization by Entrainment.
    Shirai Y; Liang JJ; Santangeli P; Arkles JS; Schaller RD; Supple GE; Nazarian S; Garcia FC; Lin D; Dixit S; Callans DJ; Marchlinski FE; Frankel DS
    Circ Arrhythm Electrophysiol; 2019 Jul; 12(7):e007249. PubMed ID: 31296041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Catheter ablation of ventricular tachycardia in patients with structural heart disease].
    Lindemann F; Darma A; Hindricks G
    Herz; 2022 Apr; 47(2):129-134. PubMed ID: 35262743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter-defibrillator.
    Strickberger SA; Man KC; Daoud EG; Goyal R; Brinkman K; Hasse C; Bogun F; Knight BP; Weiss R; Bahu M; Morady F
    Circulation; 1997 Sep; 96(5):1525-31. PubMed ID: 9315542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Prospective, Multicentre Randomised Controlled Trial Comparing Catheter Ablation Versus Antiarrhythmic Drugs in Patients With Structural Heart Disease Related Ventricular Tachycardia: The CAAD-VT Trial Protocol.
    ; Bennett RG; Campbell T; Garikapati K; Kotake Y; Turnbull S; Kanawati J; Wong MS; Qian P; Thomas SP; Chow CK; Kovoor P; Robert Denniss A; Chik W; Marschner S; Kistler P; Haqqani H; Rowe M; Voskoboinik A; Lee G; Jackson N; Sanders P; Roberts-Thomson K; Chan KH; Sy R; Pathak R; Kanagaratnam L; Chia K; El-Sokkari I; Hallani H; Kanthan A; Burgess D; Kumar S
    Heart Lung Circ; 2023 Feb; 32(2):184-196. PubMed ID: 36599791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-Scar-Related and Purkinje-Related Ventricular Tachycardia in Patients With Structural Heart Disease: Prevalence, Mapping Features, and Clinical Outcomes.
    Shirai Y; Liang JJ; Hirao K; Hyman MC; Kumareswaran R; Arkles JS; Schaller RD; Supple GE; Frankel DS; Nazarian S; Riley MP; Garcia FC; Lin D; Dixit S; Callans DJ; Marchlinski FE; Santangeli P
    JACC Clin Electrophysiol; 2020 Feb; 6(2):231-240. PubMed ID: 32081228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.
    Carbucicchio C; Santamaria M; Trevisi N; Maccabelli G; Giraldi F; Fassini G; Riva S; Moltrasio M; Cireddu M; Veglia F; Della Bella P
    Circulation; 2008 Jan; 117(4):462-9. PubMed ID: 18172038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of high-density endocardial and epicardial mapping for catheter ablation of hemodynamically unstable ventricular tachycardia.
    Cesario DA; Vaseghi M; Boyle NG; Fishbein MC; Valderrábano M; Narasimhan C; Wiener I; Shivkumar K
    Heart Rhythm; 2006 Jan; 3(1):1-10. PubMed ID: 16399044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry.
    Jefic D; Joel B; Good E; Morady F; Rosman H; Knight B; Bogun F
    Heart Rhythm; 2009 Feb; 6(2):189-95. PubMed ID: 19187909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of simultaneous unipolar radiofrequency catheter ablation for intramural septal ventricular tachycardia in nonischemic cardiomyopathy.
    Yang J; Liang J; Shirai Y; Muser D; Garcia FC; Callans DJ; Marchlinski FE; Santangeli P
    Heart Rhythm; 2019 Jun; 16(6):863-870. PubMed ID: 30576879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STRA-MI-VT (STereotactic RadioAblation by Multimodal Imaging for Ventricular Tachycardia): rationale and design of an Italian experimental prospective study.
    Carbucicchio C; Jereczek-Fossa BA; Andreini D; Catto V; Piperno G; Conte E; Cattani F; Rondi E; Vigorito S; Piccolo C; Bonomi A; Gorini A; Pepa M; Mushtaq S; Fassini G; Moltrasio M; Tundo F; Marvaso G; Veglia F; Orecchia R; Tremoli E; Tondo C
    J Interv Card Electrophysiol; 2021 Sep; 61(3):583-593. PubMed ID: 32851578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.